ALEVETABS 220 mg, film-coated tablet 24 tablets
Active ingredients: Naproxen sodium
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet24 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALEVETABS 220 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC opaque/aluminium de 24 comprimé(s)
- Marketing authorisation holder
- BAYER HEALTHCARE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Dec 2014
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62237910CIP72742869CIP133400927428692Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NAPROXÈNE SODIQUEcomprimé | 220 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.